On‐Chip Fabrication of Paclitaxel‐Loaded Chitosan Nanoparticles for Cancer Therapeutics

The use of solvent-free microfluidics to fine-tune the physical and chemical properties of chitosan nanoparticles for drug delivery is demonstrated. Nanoparticle self-assembly is driven by pH changes in a water environment, which increases biocompatibility by avoiding organic solvent contamination common with traditional techniques. Controlling the time of mixing (2.5–75 ms) during nanoparticle self-assembly enables us to adjust nanoparticle size and surface potential in order to maximize cellular uptake, which in turn dramatically increases drug effectiveness. The compact nanostructure of these nanoparticles preserves drug potency better than previous nanoparticles, and is more stable during long-term circulation at physiological pH. However, when the nanoparticles encounter a tumor cell and the associated drop in pH, the drug contents are released. Moreover, the loading efficiency of hydrophobic drugs into the nanoparticles increases significantly from previous work to over 95%. The microfluidic techniques used here have applications not just for drug-carrying nanoparticle fabrication, but also for the better control of virtually any self-assembly process.

[1]  C. Iversen,et al.  Light scattering study of semidilute aqueous systems of chitosan and hydrophobically modified chitosans , 1998 .

[2]  Robert Langer,et al.  Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. , 2012, Nano letters.

[3]  A. Vila,et al.  Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. , 2006, Investigative ophthalmology & visual science.

[4]  V. Stella,et al.  Degradation of paclitaxel and related compounds in aqueous solutions I: epimerization. , 2008, Journal of pharmaceutical sciences.

[5]  Mohammad Mahdi Hasani-Sadrabadi,et al.  Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents. , 2013, Lab on a chip.

[6]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[7]  M. M. Hasani-Sadrabadi,et al.  The effect of isopropanol addition on enhancement of transdermal controlled release of ibuprofen from ethylene vinyl acetate copolymer membranes , 2011 .

[8]  L. Juillerat-Jeanneret,et al.  Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[10]  Robert Langer,et al.  Microfluidic technologies for accelerating the clinical translation of nanoparticles. , 2012, Nature nanotechnology.

[11]  A. Kjøniksen,et al.  Optical-scattering method for the determination of the local polymer concentration inside nanoparticles. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.

[12]  Mohammad Mahdi Hasani-Sadrabadi,et al.  Microfluidic synthesis of chitosan-based nanoparticles for fuel cell applications. , 2012, Chemical communications.

[13]  C. Chuang,et al.  Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. , 2010, Biomaterials.

[14]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[15]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[16]  Kristian Berg,et al.  Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways. , 2012, International journal of biological macromolecules.

[17]  Nicholas A Peppas,et al.  Expert opinion: Responsive polymer nanoparticles in cancer therapy. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  Hsing-Wen Sung,et al.  pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: in vitro characteristics and in vivo biocompatibility. , 2009, Biomaterials.

[19]  Ashutosh Chilkoti,et al.  Nanomaterials for Drug Delivery , 2012, Science.

[20]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[21]  Robert K Prud'homme,et al.  Mechanism for rapid self-assembly of block copolymer nanoparticles. , 2003, Physical review letters.

[22]  Min Huang,et al.  Uptake of FITC-Chitosan Nanoparticles by A549 Cells , 2002, Pharmaceutical Research.

[23]  K. Vårum,et al.  Quantitative determination of chitosans by ninhydrin , 1999 .

[24]  B. Vincent,et al.  Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Kurt E. Geckeler,et al.  Paclitaxel‐Loaded Polymer Nanoparticles for the Reversal of Multidrug Resistance in Breast Cancer Cells , 2011 .

[26]  Eun Seong Lee,et al.  Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Kjøniksen,et al.  Effects of ionic strength on the size and compactness of chitosan nanoparticles , 2012, Colloid and Polymer Science.

[28]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[29]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[30]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[31]  Yanbin Fan,et al.  The intranuclear release of a potential anticancer drug from small nanoparticles that are derived from intracellular dissociation of large nanoparticles. , 2012, Biomaterials.

[32]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[33]  H. Sung,et al.  The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[35]  E. Curotto,et al.  Quantitative determination of chitosan and the percentage of free amino groups. , 1993, Analytical biochemistry.

[36]  A Pizzoferrato,et al.  In vitro evaluation of cell/biomaterial interaction by MTT assay. , 1993, Biomaterials.

[37]  P. Renaud,et al.  Morphological tuning of polymeric nanoparticles via microfluidic platform for fuel cell applications. , 2012, Journal of the American Chemical Society.

[38]  D. Kingston,et al.  Promotion of tubulin assembly by poorly soluble taxol analogs. , 2007, Analytical biochemistry.

[39]  David Sinton,et al.  Flow-directed block copolymer micelle morphologies via microfluidic self-assembly. , 2011, Journal of the American Chemical Society.